TABLE 5.

Number of countries purchasing different formulations of anti-tuberculosis medicines

Formulation	Countries n
RHZ 60/30/150	24
RH 60/60	6
RH 60/30	18
RH 150/75	4
RH 300/150	2
RHZE 150/75/400/275	7
R 100 mg/5 ml susp.	9
H 100	21
H 300	3
Z 100	1
Z 500	9
E 100	12
E 400	11
S 1000 (1g)	13
Other	India: paediatric patient wise boxes* Indonesia: combipacs R 450, H 300, Z 500, E 250 or R 450, H 300†

^*Medicines were provided in patient-wise boxes, mainly by local manufacturers, per the requirements of the Indian RNTCP.

^†Combipacks were produced by state manufacturers using the government budget, while the Global Fund allocation for paediatric TB remains unabsorbed. In 2012, the state manufacturer started producing paediatric FDCs matching the new dosage recommendations.

R = rifampicin; H = isoniazid; Z = pyrazinamide; E = ethambutol; S = streptomycin; RNTCP = Revised National Tuberculosis Control Programme.